Blondel, V. D., Guillaume, J. L., Lambiotte, R. & Lefebvre Fast unfolding of communities in large networks. J. Stat. Mech 10008, 1-12(2008). Available at: https://doi.org/10.1088/1742-5468/2008/10/P10008
Brown, G, Otero, L, LeGris, M, & Brown, R (1994) ‘Pyruvate dehydrogenase deficiency’, Journal of Medical Genetics, vol. 31, no. 11, pp. 875-879.
Byrd, D, Krohn, H, Winkler, L, Steinborn, C, Hadam, Brodehl, J, & Hunneman, D (1989)‘Neonatal pyruvate dehydrogenase deficiency with lipoate responsive lactic acidaemia and hyperammonaemia’ European Journal of Pediatrics, vol. 148, pp. 543–547.
Cameron, J. M., Janer, A., Levandovskiy, V., Mackay, N., Rouault, T. A., Tong, W. H., Ogilvie, I., Shoubridge, E. A., & Robinson, B. H. (2011)Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes. American journal of human genetics, 89(4), 486–495. Available at: https://doi.org/10.1016/j.ajhg.2011.08.011
Clauset, A., Newman, M. E., & Moore, C. “Finding community structure in very large networks.” Physical Review E 70(6), (2004).
Mayr, Johannes A et al. “Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation.” American journal of human genetics vol. 89,6 (2011): 792-7. Available at: https://doi:10.1016/j.ajhg.2011.11.011
DLAT dihydrolipoamide S-acetyltransferase [ Homo sapiens (human) ] (2022) National Library of Medicine. Available at: https://www.ncbi.nlm.nih.gov/gene/1737
Ebertowska, A, Ludkiewicz, B, Klejbor, I, Melka, N, & Morys, J (2020), Pyruvate dehydrogenase deficiency: morphological and metabolic effects, creation of animal model to search for curative treatment’, Folia Morphologica, vol. 79, no. 2, pp. 191-197.
Ferriero, R, Boutron, A, Brivet, M, Kerr, D, Morava, E, Rodenburg, RJ, Bonafé, L, Baumgartner, MR, Anikster, Y, Braverman, NE & Brunetti‐Pierri, N (2014) ‘Phenylbutyrate increases pyruvate dehydrogenase complex activity in cells harboring a variety of defects’, Annals of Clinical and Translational Neurology, vol. 1, no. 7, pp. 462–470.
Ganetzky, R., McCormick, E. M., & Falk, M. J. (2021). Primary Pyruvate Dehydrogenase Complex Deficiency Overview.
Gottwald, G. ed., (2022). Lecture Weeks - 1,2,3.
Greedy_modularity_communities# (no date) greedy_modularity_communities - NetworkX 2.8.7 documentation.
Jain, Anshika et al. “Assembly of the [4Fe-4S] cluster of NFU1 requires the coordinated donation of two [2Fe-2S] clusters from the scaffold proteins, ISCU2 and ISCA1.” Human molecular genetics vol. 29,19 (2020): 3165-3182. Available at: https://doi:10.1093/hmg/ddaa172
Liu, R., Feng, S., Shi, R. and Guo, W., (2014) Weighted graph clustering for community detection of large social networks. Procedia Computer Science, 31, pp.85-94.
Miura, K (2018), ‘An Overview of Current Methods to Confirm Protein- Protein Interactions’, Protein & Peptide Letters, vol. 25, no. 8, pp. 728–733.
Navarro-Sastre, A., Tort, F., Stehling, O., Uzarska, M. A., Arranz, J. A., Del Toro, M., Labayru, M. T., Landa, J., Font, A., Garcia-Villoria, J., Merinero, B., Ugarte, M., Gutierrez-Solana, L. G., Campistol, J., Garcia-Cazorla, A., Vaquerizo, J., Riudor, E., Briones, P., Elpeleg, O., Ribes, A., … Lill, R. (2011). A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins. American journal of human genetics, vol. 89, no. 5, pp. 656–667. Available at: https://doi.org/10.1016/j.ajhg.2011.10.005
Nielsen, K. H. (2014). "Chapter Twelve - Protein Expression-Yeast." LORSCH, J. (ed.) Methods in Enzymology. Academic Press.
Overview of Protein–Protein Interaction Analysis - US (n.d.).
Patel, K, O'Brien, T, Subramony, S, Shuster, J, & Stacpoole, P (2012) ‘The spectrum of pyruvate dehydrogenase complex deficiency: Clinical, biochemical and genetic features in 371 patients’ Molecular Genetics and Metabolism, vol. 105, no. 1, pp. 34-43.
Pavlu-Pereira, H, Silva, M, Florindo, C, Sequeira, S, Ferriera, A, Duarte, S, Rodrigues, A, Janeiro, P, Oliveira A, Gomes, D, Bandeira, A, Martins, E, Gomes, R, Soares, S, Tavares de Almeida, I, Vincente, J, & Rivera, I (2020) ‘Pyruvate dehydrogenase complex deficiency: updating the clinical, metabolic and mutational landscapes in a cohort of Portuguese patients’, Orphanet Journal of Rare Diseases, vol. 15, no. 298, pp. 1-14.
Pietikäinen, LP, Rahman, MT, Hiltunen, JK, Dieckmann, CL & Kastaniotis, AJ (2021), ‘Genetic dissection of the mitochondrial lipoylation pathway in yeast’, BMC Biology, vol. 19, no. 1.
Pirot, N, Crahes, M, Adle-Biassette, H, Soares, A, Bucourt, M, Boutron, A, Carbillon, L, Mignot, C, Trestard, L, Bekri, S, & Laquerrière, A (2016) Phenotypic and Neuropathological Characterization of Fetal Pyruvate Dehydrogenase Deficiency’, Journal of Neuropathology & Experimental Neurology, vol. 75, no. 3, pp. 227–238.
Platta, Harald W, Girzalsky, W & Erdmann, R (2004), ‘Ubiquitination of the peroxisomal import receptor Pex5p’, Biochemical Journal, vol. 384, no. 1, pp. 37–45.
Purewal, H (2018), ‘The Effect of Alpha Lipoic Acid (ALA) on S. cerevisiae Cell Proliferation’, American Journal of Medical and Biological Research, vol. 6, no. 2, pp. 21–26.
Pliss, L, Hausknecht, K, Stachowiak, M, Dlugos, C, Richards, J, & Patel, M (2013) ‘Cerebral Developmental Abnormalities in a Mouse with Systemic Pyruvate Dehydrogenase Deficiency’, PLOS One, vol. 8, no. 6, pp. 1-14.
Ran, FAFA., Hsu, PD, Wright, J, Agarwala, V, Scott, DA, & Zhang, F (2013), Genome engineering using the CRISPR-Cas9 system. Nature protocols, vol. 8 no. 11, pp. 2281-2308.
Sardhara, H (2021) Regulation of PDH complex, Biotechfront.
Schonauer, MS, Kastaniotis, AJ, Kursu, VAS, Hiltunen, JK & Dieckmann, CL (2009), ‘Lipoic Acid Synthesis and Attachment in Yeast Mitochondria’, Journal of Biological Chemistry, vol. 284, no. 35, pp. 23234–23242.
Soreze, Y., Boutron, A., Habarou, F., Barnerias, C., Nonnenmacher, L., Delpech, H., ... & de Lonlay, P. (2013). Mutations in human lipoyltransferase gene LIPT1 cause a Leigh disease with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase. Orphanet journal of rare diseases, vol. 8, no. 1, pp. 1-9.
Stacpoole, PW, Kurtz, TL, Han, Z & Langaee, T (2008), ‘Role of dichloroacetate in the treatment of genetic mitochondrial diseases☆’, Advanced Drug Delivery Reviews, vol. 60, no. 13-14, pp. 1478–1487.
Storm, J, & Muller, S (2012), ‘Lipoic Acid Metabolism of Plasmodium - A Suitable Drug Target’, Current Pharmaceutical Design, vol. 18, no. 24, pp. 3480-3489.
Traag, V.A., Waltman, L. and van Eck, N.J. (2019) From Louvain to Leiden: Guaranteeing well-connected communities, Nature News. Nature Publishing Group. Available at: https://www.nature.com/articles/s41598-019-41695-z
Brandes U. (2008) On Variants of Shortest-Path Betweenness Centrality and their Generic Computation. Social Networks 30(2):136-145, 2008. Available at: https://doi.org/10.1016/j.socnet.2007.11.001
Warui, D. M., Sil, D., Lee, K. H., Neti, S. S., Esakova, O. A., Knox, H. L., ... & Booker, S. J. (2022). In Vitro Demonstration of Human Lipoyl Synthase Catalytic Activity in the Presence of NFU1. ACS Bio & Med Chem Au.
Yang, J. (n.d.) Yeast Two Hybrid.
Yoshida, I, Sweetman, L, Kulovich, S, Nyhan, W, & Robinson, B (1990) ‘Effect of Lipoic Acid in a Patient with Defective Activity of Pyruvate Dehydrogenase, 2-Oxoglutarate Dehydrogenase, and Branched- Chain Keto Acid Dehydrogenase’ Pediatric Research, vol. 27, pp. 75-79.
